The incidence of otalgia decreased from 89 % ( 16/18 ) in the isotonic sodium chloride-treated group to 63 % ( 12/19 ) in the ropivacaine-treated and 61 % ( 11/18 ) in the ropivacaine plus clonidine-treated groups ( P < .01 ) .
